Explore the impact of Real World Evidence (RWE) on healthcare decision-making among regulators, payers, and patients throughout the Asia-Pacific region. With emerging AI applications, evolving reimbursement policies, and new strategies in rare disease research, pharmaceutical companies must adapt to leverage RWE effectively. This virtual conference will explore key developments and best practices to integrate RWE into decision-making across diverse healthcare landscapes.
Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
